Assertio Holdings Inc

General ticker "ASRT" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $90.4M

Assertio Holdings Inc follows the US Stock Market performance with the rate: 27.3%.

Estimated limits based on current volatility of 3.8%: low 0.84$, high 0.90$

Factors to consider:

  • Price in estimated range
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.56$, 1.58$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.49$, 1.26$]

Financial Metrics affecting the ASRT estimates:

  • Negative: Operating profit margin, % of -61.56 <= 1.03
  • Positive: 0.10 < Non-GAAP EPS, $ of 0.18
  • Negative: Industry earnings per price (median), % of -15.01 <= 1.31
  • Negative: negative Net income
  • Negative: 0 < Interest expense per share, $ of 0.05

Similar symbols

Short-term ASRT quotes

Long-term ASRT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $111.01MM $156.23MM $152.07MM
Operating Expenses $101.59MM $116.83MM $395.61MM
Operating Income $9.42MM $39.41MM $-243.54MM
Non-Operating Income $-9.98MM $-8.24MM $-10.52MM
Interest Expense $10.22MM $7.96MM $3.38MM
R&D Expense $0.00MM $0.00MM $2.84MM
Income(Loss) $-0.55MM $31.17MM $-254.05MM
Taxes $0.73MM $-78.46MM $77.89MM
Profit(Loss) $-1.28MM $109.62MM $-331.94MM
Stockholders Equity $102.41MM $225.72MM $138.00MM
Inventory $7.49MM $13.70MM $37.69MM
Assets $326.55MM $413.91MM $286.42MM
Operating Cash Flow $5.52MM $78.60MM $49.60MM
Capital expenditure $0.05MM $0.27MM $0.63MM
Investing Cash Flow $-18.52MM $-42.67MM $3.10MM
Financing Cash Flow $29.03MM $-7.79MM $-44.20MM
Earnings Per Share* $-0.03 $2.33 $-4.67

* EPS are Split Adjusted, recent splits may be reflected with a delay.